Skip to main content

Dr Debashis Sarker

Reader and Consultant in Medical Oncology

Research interests

  • Cancer

Biography

Dr Debashis Sarker is a Senior Lecturer within the Comprehensive Cancer Centre and Consultant in Medical Oncology. 

    Research

    GI cancer programme 780x440
    Programme in Gastrointestinal Cancer

    The Programme in GI Cancer focuses on GI tract diseases, mostly cancer and oesophago-gastric cancer. This group spans a broad field of interests, promoting collaborative working within KCL, nationally and internationally.

    Novel immunotherapy 780x440
    Cancer Early Phase Trials Unit

    Led by Professor James Spicer, Dr Debashis Sarker and Dr Rebecca Kristeleit, the Cancer Early Phase Trials Unit focuses on the discovery and development of novel molecular and cellular cancer immunotherapies.

    experimental-oncology
    Experimental Oncology

    The Experimental Oncology Programme is focused on the development of new treatments for solid tumours.

    Project status: Ongoing

    News

    COVID reforms in cancer care and research could have long-term benefits

    A new review led by Professor James Spicer considers the reforms in cancer care and research made due to the pandemic, arguing that some have left a positive...

    cancer care post covid 780×450

    Experimental cancer treatments receive funding boost

    King's Health Partners (KHP) Experimental Cancer Medicine Centre (ECMC) has had its funding renewed for the next five years.

    Cancer globally

      Research

      GI cancer programme 780x440
      Programme in Gastrointestinal Cancer

      The Programme in GI Cancer focuses on GI tract diseases, mostly cancer and oesophago-gastric cancer. This group spans a broad field of interests, promoting collaborative working within KCL, nationally and internationally.

      Novel immunotherapy 780x440
      Cancer Early Phase Trials Unit

      Led by Professor James Spicer, Dr Debashis Sarker and Dr Rebecca Kristeleit, the Cancer Early Phase Trials Unit focuses on the discovery and development of novel molecular and cellular cancer immunotherapies.

      experimental-oncology
      Experimental Oncology

      The Experimental Oncology Programme is focused on the development of new treatments for solid tumours.

      Project status: Ongoing

      News

      COVID reforms in cancer care and research could have long-term benefits

      A new review led by Professor James Spicer considers the reforms in cancer care and research made due to the pandemic, arguing that some have left a positive...

      cancer care post covid 780×450

      Experimental cancer treatments receive funding boost

      King's Health Partners (KHP) Experimental Cancer Medicine Centre (ECMC) has had its funding renewed for the next five years.

      Cancer globally